As of 2026-04-08, the Intrinsic Value of Immunic Inc (IMUX) is -3.72 USD. This IMUX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.19 USD, the upside of Immunic Inc is -412.96%.
Based on its market price of 1.19 USD and our intrinsic valuation, Immunic Inc (IMUX) is overvalued by 412.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.72 - -3.72 | -3.72 | -412.96% |
| DDM - Stable | (4.41) - (15.85) | (10.13) | -951.0% |
| DDM - Multi | (0.36) - (1.07) | (0.55) | -146.0% |
| Market Cap (mil) | 155.25 |
| Beta | 0.55 |
| Outstanding shares (mil) | 130.46 |
| Enterprise Value (mil) | 139.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.03% |
| Cost of Debt | 5.00% |
| WACC | 7.85% |